Introducing the projects that aim to elucidate the role of protists in food sensitivity, identify novel bioactives to prevent or reduce inflammatory bowel disease (IBD), and look for antibody–antigen interactions in microbiome-related diseases.
Advertisement Feature |
Supporting innovative research into the human microbiome
Researchers are embracing the gut microbiome. Our microflora do more than keep the intestines in check, they also affect our immune system and mental health. These new grants support investigators exploring the microbiome’s influence.
Awarded grants 2020
Computational biologist Eran Segal will use his Global Grant for Gut Health to examine how the microbiome and immune system interact, and how it can go awry.
Biochemist and inflammatory bowel disease (IBD) specialist, Jakob Begun, will use his Global Grant for Gut Health to explore how microbial power could limit IBD progression.
Immunologist Reinhard Hinterleitner will use his Global Grant for Gut Health to examine whether certain microbes, known as protists, have a protective role in food sensitivities.
Awarded grants 2019
We’re proud to present two highly competitive projects that investigate long-term evolution in the gut microbiome and drug-microbiome interactions.
Adding to research focused on the overall composition of the gut microbiome, biologist Isabel Gordo will use her Global Grant for Gut Health to explore the evolutionary path of one common gut bacterium, Escherichia coli, inside living animals.
After many years studying the gastrointestinal tract, pharmacologist and senior physiology lecturer Niall Hyland will use his Global Grant for Gut Health to examine how the microbiome influences the ability to metabolise anti-depressant or anti-psychotic drugs.